ANTIBODIES

Contributor Information
- Institute Cancer Research UK, London Research Institute: Lincoln's Inn Fields
Tool Details
- Tool name: Anti-CLEC9A [397]
- Alternate names: C-Type Lectin Domain Family 9 Member A; HEEE9341; UNQ9341; DNGR-1; CD37; DNGR1
- Clone: 397
- Tool type: Antibodies
- Tool sub-type: Primary antibody
- Class: Monoclonal
- Conjugate: Unconjugated
- Reactivity: Mouse
- Host: Rat
- Application: WB
- Description: Recognises mouse DNGR-1, also known as CLEC9A, which is a highly specific marker of the CD8a+ and the CD103+ DC subsets, as well as a receptor able to recognise a preformed signal exposed on necrotic cells.
- Immunogen: RBL-2H3 cells expressing mouse DNGR-1 fused to an HA epitope
- Isotype: IgG2a
- Research area: Immunology; Stem cell biology
- Myeloma used: Y3.AG.1.2.3
- For Research Use Only
Target Details
- Target: Mouse DNGR1
- Target background: Recognises mouse DNGR-1, also known as CLEC9A, which is a highly specific marker of the CD8a+ and the CD103+ DC subsets, as well as a receptor able to recognise a preformed signal exposed on necrotic cells.
Application Details
- Application: WB
Handling
- Format: Liquid
- Concentration: 1 mg/ml
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15ðC to -25ðC
- Shipping conditions: Shipping at 4ðC
Related Tools
References
- • Joffre et al. 2010. Eur J Immunol. 40(5):1255-65. PMID: 20333625.
- • Efficient and versatile manipulation of the peripheral CD4+ T-cell compartment by antigen targeting to DNGR-1/CLEC9A.
- • Sancho et al. 2009. Nature. 458(7240):899-903. PMID: 19219027.
- • Identification of a dendritic cell receptor that couples sensing of necrosis to immunity.
- • Sancho et al. 2008. J Clin Invest. 118(6):2098-110. PMID: 18497879.
- • Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin.